You are here

Biogen Idec

Biogen Idec Makes Bid for Facet for $14.50 a Share

Bloomberg

Mon, 09/21/09 - 09:56 am

MS drug Tysabri reawakens brain virus -study

Forbes/Reuters

Thu, 09/10/09 - 11:31 am

multiple sclerosis

Top Facet Investor's Big Sell-Off

InVivo

Thu, 09/10/09 - 10:44 am

Biogen Maintains Facet Offer

Yahoo/Zacks.com

Thu, 09/10/09 - 08:52 am

Acorda Therapeutics

Bristol-Myers Squibb

Cell Therapeutics Fails to Impress

Yahoo/Zacks.com

Tue, 09/8/09 - 08:01 pm

Cell Therapeutics

Why Funds Missed Facet Biotech

Minyanville

Tue, 09/8/09 - 01:56 pm

Facet Biotech rejects Biogen Idec's bid

Marketwatch

Tue, 09/8/09 - 08:32 am

Facet Biotech Should Dig in Its Heels over Biogen Bid

Seeking Alpha

Tue, 09/8/09 - 06:16 am

Exiting Facet Biotech on Biogen's Offer

Seeking Alpha

Mon, 09/7/09 - 08:43 am

Biogen Idec offers to buy Facet for $356M

Triangle Business News

Sun, 09/6/09 - 01:00 pm

J&J stake in Elan could rise to 20pc after US court ruling

Independent, Ireland

Sat, 09/5/09 - 12:44 pm

Biogen Idec offers to buy Facet for $356M

Bizjournals.com

Sat, 09/5/09 - 12:42 pm

Elan dealt a blow with Biogen ruling

FT.com

Thu, 09/3/09 - 10:01 pm

Order In The Court! New Date for Biogen/Elan Hearing

InVivo

Thu, 09/3/09 - 10:50 am

Biogen granted more time in drug dispute with Elan

Irish Independent

Wed, 08/26/09 - 07:52 pm

Spotlight on Biotech: 10 Promising Companies

Seeking Alpha

Sun, 08/9/09 - 11:59 am

Myriad Genetics

Teva Pharmaceuticals

Warner Chilcott

Pharma Cash for Clunkers

InVivo

Sun, 08/9/09 - 11:54 am

Arcion Therapeutics

A Billion-Dollar Lovers' Quarrel

Motley Fool

Sat, 08/8/09 - 12:30 pm

Elan starts legal action in drug row with Biogen

FT.com

Thu, 08/6/09 - 07:22 pm

Another Blow for Biogen's Tysabri

Yahoo/Zacks.com

Wed, 07/29/09 - 03:47 pm

multiple sclerosis

Pages